Aimmune Therapeutics

-$0.10 (-0.29%) Today
$0.00 (0.00%) As of 11:11 PM UTC after-hours

Why Robinhood?

You can watch AIMT and buy or sell other stocks, options, and ETFs commission-free!

About AIMT

Aimmune Therapeutics is a company operating in the United States biotechnology industry. Its main focus is in the development of product candidates to combat peanut and other food allergies.

CEO
Andrew Oxtoby, MBA
Employees
—
Headquarters
Brisbane, California
Founded
2011

AIMT Key Statistics

Market cap
2.26B
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.45M
High today
—
Low today
—
Open price
—
Volume
0.00
52 Week high
$37.00
52 Week low
$10.09

AIMT Earnings

-$1.09
-$0.73
-$0.36
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 25, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure